Table 1 Relationship of FGFR3 with different clinicopathologic parameters of melanoma patients
| Parameters | FGFR3 expression | |||
|---|---|---|---|---|
| n | Low | High | P | |
| Age | ||||
| ≤ 60 | 29 | 19 | 10 | NS |
| > 60 | 13 | 7 | 6 | |
| Gender | ||||
| Male | 25 | 17 | 8 | NS |
| Female | 17 | 9 | 8 | |
| Location | ||||
| Head/neck | 2 | 1 | 1 | NS |
| Trunk | 29 | 18 | 11 | |
| Extremities | 8 | 5 | 3 | |
| Feet | 3 | 2 | 1 | |
| Breslow thickness | ||||
| 1.01–2.00 | 14 | 12 | 2 | 0.0119 |
| 2.01–4.00 | 15 | 6 | 9 | |
| > 4.00 | 13 | 8 | 5 | |
| Clark Classification | ||||
| I-II | 9 | 6 | 3 | NS |
| III-IV | 33 | 20 | 13 | |
| Ulceration | ||||
| Yes | 20 | 10 | 10 | NS |
| No | 22 | 16 | 6 | |
| Nodular | ||||
| Yes | 17 | 9 | 8 | NS |
| No | 25 | 17 | 8 | |
| SLN status | ||||
| Not involved | 27 | 21 | 6 | 0.0045 |
| Involved | 15 | 5 | 10 | |
